Condition
Myocardial Infarction (MI) clinical trials and research
As of November 12, 2026, Find a Trial lists 35 Myocardial Infarction (MI) clinical trials that are recruiting, at sites in 23 countries (most in China (5), South Korea (4), France (3)). By phase: Phase 3 (2), Phase 4 (1). The most active sponsors are Chonnam National University Hospital (3), Chinese Academy of Medical Sciences, Fuwai Hospital (2), National Taiwan University Hospital (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 35Clinical trials
- 23Countries
Newest Myocardial Infarction (MI) clinical trials
All recruiting trials (35)
-
Risk of malignant arrhythmias after acute coronary syndrome
This study tracks how often dangerous heart rhythms occur in adults admitted for ACS and looks for patterns that might predict them.
-
Smartphone AI help for prehospital ECG readings
This study tests whether using a smartphone AI (GPT-4o) to help prehospital providers read 12-lead ECGs improves accuracy in diagnosing acute coronary syndromes and related conditions.
-
Optimal timing of staged complete revascularization in STEMI with multivessel disease
This trial tests whether performing staged complete revascularization during the hospital stay or after discharge is best for STEMI patients with multivessel disease.
-
BEAT-SHOCK: Baseline Registry for Acute Cardiogenic Shock at Basel
This registry collects and shares data on adults with cardiogenic shock admitted to University Hospital Basel to help understand how these patients are treated and how they fare.
-
Low-dose IL-2 after heart attack to study tissue-resident regulatory T cells
Researchers are testing whether low-dose interleukin-2 given after a myocardial infarction can boost tissue-resident regulatory T cells to support heart repair.
-
Abbreviated antithrombotic therapy after PCI in AF and MI
This trial tests whether DOAC-only therapy works as well as DOAC plus clopidogrel after PCI in people with atrial fibrillation and a recent heart attack.
-
Prehospital High-Sensitivity Troponin I to rule out heart attack for EMS patients
EMS patients with chest pain or possible heart symptoms are being studied to see if a portable hs-TnI test in the ambulance can help identify those at low risk for a heart attack.
-
Markers to Predict Sudden Cardiac Death Risk After MI with Moderate LVEF
This study tests a risk-score approach to see if certain MRI findings, biomarkers, and other tests can predict sudden cardiac death in people who survived a heart attack and have moderately reduced heart function.
-
Prasugrel vs Ticagrelor and 1–3 months vs 12 months of DAPT after MI treated with PCI
This trial tests whether a shorter duration of dual antiplatelet therapy plus one drug is as safe and effective as a full 12 months of therapy, and whether prasugrel or ticagrelor works better after a heart attack treated with PCI.
-
SGLT2 inhibitor effects on artery stiffness, vessel lining thickness, and heart muscle after a heart attack
This project will see if SGLT2 inhibitors given after a heart attack improve blood vessel stiffness, the vessel's protective lining, and heart muscle function for people with type 2 diabetes or reduced heart pumping.
-
Drug-coated balloon treatment during emergency angioplasty for STEMI
This registry will try using drug-coated balloons instead of stents during emergency PCI for people with ST-elevation heart attacks to see how the procedure and patient outcomes compare.
-
ECG-less gated cardiac CT to detect coronary blockages after cardiac arrest without ST-elevation
This test will see if ECG-less gated cardiac CT can find narrowed or blocked coronary arteries in adults who were resuscitated from cardiac arrest but do not have ST-elevation on their ECG.
-
T1 mapping to characterize heart tissue in common heart diseases
This project tests whether T1 mapping MRI scans, including dye-free native T1, can define normal and disease-specific heart tissue values for adults with various heart conditions.
-
Outcomes in patients with mixed cardiogenic and vasoplegic shock
This registry will try to describe outcomes and risk factors in adults admitted with cardiogenic shock who also have inappropriate vasodilation (mixed cardiogenic‑vasoplegic shock).
-
CMR markers that predict outcomes after ischemic heart disease or heart attack
This study will test whether specific heart MRI (CMR) features can help predict long-term risk in adults with ischemic heart disease or a prior myocardial infarction.
-
Montelukast to protect the heart after an anterior STEMI
This trial will test whether giving montelukast around the time of primary PCI can reduce heart damage and later heart failure in adults with anterior STEMI.
-
Norwegian SCAD follow-up and outcomes program
This program will follow adults hospitalized with SCAD in Norway for one year to see if scheduled imaging, tests, and questionnaires identify complications and risk factors.
-
Comparing core, aerobic, and combined exercise during Phase II cardiac rehabilitation
This trial tests whether adding Pilates-style core exercises, standard aerobic exercise, or both to Phase II cardiac rehab improves fitness, balance, and quality of life for adults with recent myocardial infarction or stable heart failure.
-
Endo-epicardial versus endocardial catheter ablation for post-heart attack ventricular tachycardia
This study will see if adding an epicardial approach (through the pericardial sac) to standard endocardial catheter ablation reduces recurrent ventricular tachycardia in people who have had a heart attack and have an ICD.
-
Telegram-based smoking-cessation support after heart attack
This trial tests whether a 6-month Telegram chatbot program helps people who had a heart attack quit smoking more often than standard care alone.
-
Algae supplements for heart risk markers and gut health
This trial will test whether daily supplements of spirulina or Gelidium corneum change gut microbes and improve heart‑disease risk markers in adults over 50 with cardiovascular disease, diabetes, or related conditions.
-
Heart MRI scar analysis to predict sudden cardiac death after a heart attack
This study will see if detailed heart MRI scar pictures can predict out-of-hospital sudden cardiac death in people who have had a heart attack.
-
Contrast perfusion ultrasound to help diagnose heart attacks in patients with suspected NSTEMI
We will test whether contrast-enhanced myocardial perfusion ultrasound can identify heart attacks or alternative causes in adults hospitalized with suspected non‑ST‑elevation acute coronary syndrome who are planned for coronary angiography.
-
AI reading of ECGs to find occlusion myocardial infarction
This trial tests whether an AI tool that reads ECGs can help doctors identify and treat occlusion myocardial infarction faster in adults with suspected acute coronary syndrome who don't meet STEMI criteria.
-
Using cardiac MRI and AI to predict outcomes after STEMI
This project will try to use routine cardiac MRI scans plus AI to see if imaging features can predict long-term outcomes in people who had a STEMI treated with primary PCI.
-
Continuing versus stopping daily aspirin before colonoscopy with possible polyp removal
This trial tests whether people taking daily low‑dose aspirin to prevent heart problems should keep taking aspirin or stop it before an elective colonoscopy with possible polyp removal to balance heart and bleeding risks.
-
AI ECG to quickly rule out heart attack (ROMIAE 2)
This study will test whether using an AI-read ECG can safely and quickly rule out heart attack in people who come to the emergency department with chest pain and suspected myocardial infarction.
-
Targeted look at residual inflammation after a heart attack
This project will test whether the neutrophil-to-lymphocyte ratio (NLR) from the first routine blood draw can help predict risk of death in adults (18–85) after an acute coronary syndrome treated with PCI.
-
When to do coronary angiography for NSTEMI with acute heart failure
This trial will test whether doing coronary angiography immediately (within 2 hours) versus delaying it after stabilization reduces deaths, heart attacks, or heart-failure hospitalizations over 12 months in adults with NSTEMI complicated by acute decompensated heart failure.
-
Optimizing risk prediction after a heart attack (ORACLE)
This project will try to use wearable data, blood tests, imaging, and AI to better predict bleeding and repeat heart events in people who've had a heart attack and are at high risk.
-
Comparing mini-crush and controlled balloon-crush techniques for treating coronary bifurcation lesions
This study is testing whether two different stenting techniques, mini-crush and controlled balloon-crush, work better for treating complex heart artery blockages in people with coronary bifurcation lesions.
-
Observational study of elderly patients with heart attacks
This study looks at older patients who have had heart attacks to see how their age affects their treatment and recovery.
-
Evaluating the best timing for surgery after heart attacks with ventricular defects
This study is testing the best timing for surgery in people who have heart defects after a heart attack to see how it affects their recovery.
-
Investigating delays in treatment for heart attack patients
This study looks at how delays in treatment for heart attack patients affect their recovery and survival to see if we can find ways to help them do better.
-
Genistein to lower lipids and inflammation after a heart attack
This trial will test whether taking genistein every day for three months lowers triglycerides and inflammation in adults who have had a heart attack.
Related topics
Quick answers
How many Myocardial Infarction (MI) clinical trials are recruiting right now?
35, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 23 countries. The most sites are in China (5 trials), South Korea (4 trials), France (3 trials), Spain (3 trials), Switzerland (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.